Bought
Maintained
Sold
Other funds holding ADNT
HHAM
Nuveen's ADNT Position: Q2 2026 in Review
Nuveen reduced its Adient (ADNT) stake by 40% in Q2 2026, selling an estimated $9.11M and leaving 635,245 shares worth $11.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1591.
Nuveen first reported a position in ADNT in Q2 2019 and has held it in 29 quarters since. The position peaked at $155M in Q2 2021. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.
- Nuveen held 635,245 shares of Adient worth $11.7M as of Q2 2026.
- Nuveen sold 426,357 Adient shares in Q2 2026, an estimated $9.11M.
- Adient made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1591 holding.
- Nuveen first reported a position in Adient in Q2 2019 and has held it in 29 quarters since.
- Nuveen's Adient position peaked at $155M in Q2 2021.
- 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.